Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy
about
Minireview: Regulatory T Cells and Ovarian Cancer.Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseasesPotential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapy.Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKLKilling Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation.Emerging roles of regulatory T cells in tumour progression and metastasis.Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.Perenosins: a new class of anion transporter with anti-cancer activity.Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
P2860
Q30244214-7AB177D7-F00B-441E-B56B-DAF71D4329FAQ33650813-207413DB-6474-43E3-9DBC-BB823994360EQ33940448-B05624BB-A9B3-450C-BF1B-B944548A4579Q35188522-9AE25780-CF76-4172-9022-06DBDE0320BBQ37521403-10A3E345-954C-456B-BF00-DDD5374C1A86Q38264092-AE67C1C6-34D5-40AD-A18A-4D549E6789A7Q38442515-38071A93-5B04-47DC-8D09-777282E4D174Q38791794-AF7911FB-396A-4DD7-9590-ADB5990C5AACQ46046777-B08523CD-92E6-4125-A80F-DF87D21EC56EQ52665504-59F532A5-62F2-41FA-89FD-2922987E63AAQ58763373-70B5AC31-D994-4296-A9CF-C97F8F4A5392
P2860
Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@ast
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@nl
type
label
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@ast
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@nl
prefLabel
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@ast
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@nl
P2093
P2860
P356
P1476
Pan-Bcl-2 inhibitor, GX15-070 ...... e in combination immunotherapy
@en
P2093
Caroline Jochems
Italia Grenga
James L Gulley
Jeffrey Schlom
Kwong Y Tsang
Renee N Donahue
P2860
P304
P356
10.4049/JIMMUNOL.1301369
P407
P577
2014-02-10T00:00:00Z